Other liver‐related complications · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether other plasma expanders changes other liver‐related complications compared with albumin (very low certainty).
1 finding from 1 review
Non‐serious adverse events · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether other plasma expanders changes non‐serious adverse events compared with albumin (very low certainty).
1 finding from 1 review
Serious adverse events · cirrhotic participants with large ascites treated by paracentesis
1 finding from 1 review
Health‐related quality of life · cirrhotic participants with large ascites treated by paracentesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Refractory ascites · cirrhotic participants with large ascites treated by paracentesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other liver‐related complications · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether plasma expanders changes other liver‐related complications compared with no plasma expanders (very low certainty).
1 finding from 1 review
Non‐serious adverse events · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether plasma expanders changes non‐serious adverse events compared with no plasma expanders (very low certainty).
1 finding from 1 review
All‐cause mortality · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether other plasma expanders changes all‐cause mortality compared with albumin (very low certainty).
1 finding from 1 review
Serious adverse events · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether other plasma expanders changes serious adverse events compared with albumin (very low certainty).
1 finding from 1 review
Health‐related quality of life · cirrhotic participants with large ascites treated by paracentesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · people with liver metastases
The intervention showed no clear difference in all‐cause mortality (low certainty).
1 finding from 1 review
Intervention not reported
Cancer mortality · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
All adverse events and complications · people with liver metastases
The intervention led to higher all adverse events and complications; GRADE not reported.
1 finding from 1 review
Intervention not reported
Health‐related quality of life · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Recurrence of liver metastases Number of participants developing recurrences of liver metastases · people with liver metastases
The intervention showed no clear difference in recurrence of liver metastases Number of participants developing… (low certainty).
1 finding from 1 review
Intervention not reported
Time to progression of liver metastases · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Tumour response measures · people with liver metastases
1 finding from 1 review
All‐cause mortality · patients with covert or overt hepatic encephalopathy
1 finding from 1 review
General health‐related quality of life · patients with covert or overt hepatic encephalopathy
1 finding from 1 review
Serious adverse events · patients with covert or overt hepatic encephalopathy
1 finding from 1 review